Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of USP7 induces p53-independent tumor growth suppression in triple-negative breast cancers by destabilizing FOXM1
Jingjie Yi, Huan Li, Bo Chu, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 7, pp. 1799-1810
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

USP7 as an emerging therapeutic target: A key regulator of protein homeostasis
Ning-Jie Guo, Bo Wang, Yu Zhang, et al.
International Journal of Biological Macromolecules (2024) Vol. 263, pp. 130309-130309
Closed Access | Times Cited: 13
Helicobacter pylori activates DOPEY1 to promote p53 degradation through the USP7/TRIP12 axis in gastric tumorigenesis
Yanan Zhou, Nianshuang Li, Yuchen Zhu, et al.
Oncogene (2025)
Closed Access | Times Cited: 1
SP1‐activated USP27X‐AS1 promotes hepatocellular carcinoma progression via USP7‐mediated AKT stabilisation
Su Chen, Haoquan Zhang, Jie Mo, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Ubiquitin recruiting chimera: more than just a PROTAC
Tatyana A. Grigoreva, Daria Novikova, Gerry Melino, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 4
USP13: A therapeutic target for combating tumorigenesis and antitumor therapy resistance
Lina Yi, Akezhouli Shahatiaili, Lin Zhang, et al.
International Journal of Biological Macromolecules (2025), pp. 140608-140608
Closed Access
TOR1 AIP1 interacts with p53 to enhance cell cycle dysregulation in prostate cancer progression
Zhaofeng Li, Xueyu Li, Han Yang, et al.
Molecular and Cellular Biochemistry (2025)
Open Access
FOXM1 could serve as a bridge mediating prognosis and immunity for clear cell renal cell carcinoma via single-cell and bulk RNA-sequencing
Jianhua Zhou, Zheng-fu Xu, Yang Yu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
USP33 facilitates the ovarian cancer progression via deubiquitinating and stabilizing CBX2
Jiming Chen, Wulin Shan, Qiucheng Jia, et al.
Oncogene (2024)
Closed Access | Times Cited: 3
Latest Therapeutical Approaches for Triple-Negative Breast Cancer: From Preclinical to Clinical Research
Mariona Pont, Marta Marqués, Anabel Sorolla
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13518-13518
Open Access | Times Cited: 3
Ubiquitin specific protease 7 is a potential therapeutic target for gastric cancer
Zhi-Ru Wang, Wen-Ting Kang, Ruili Yu
Frontiers in Oncology (2025) Vol. 15
Open Access
Mouse mesenchymal stem cell-derived exosomal miR-205-5p modulates LPS-induced macrophage polarization and alleviates lung injury by regulating the USP7/FOXM1 axis
Yinglu Feng, Min Tang, Haopeng Li, et al.
Drug Delivery and Translational Research (2025)
Closed Access
Role of the USP family in autophagy regulation and cancer progression
Congcong Liu, Yuan Yuan, Yuxin Zhan, et al.
APOPTOSIS (2025)
Closed Access
In vivo CRISPR screens identify Mga as an immunotherapy target in triple-negative breast cancer
Feng Xu, Chang Yang, Yuanjian Huang, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 39
Open Access | Times Cited: 2
Targeting the p53-p21 Axis in Liver Cancer: Linking Cellular Senescence to Tumor Suppression and Progression
Lakshmi Thangavelu, Abdulmalik S A Altamimi, Nehmat Ghaboura, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155652-155652
Closed Access | Times Cited: 2
Tetrahydrocurcumin targets TRIP13 inhibiting the interaction of TRIP13/USP7/c-FLIP to mediate c-FLIP ubiquitination in triple-negative breast cancer
Yujie Sun, Qiang Zhang, Shijie Cao, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 2
Therapeutic Landscape of FOXM1 in Triple-Negative Breast Cancer and Aggressive Solid Cancers
Sayra Dilmaç, Zühal Hamurcu, Bülent Özpolat
Cancers (2024) Vol. 16, Iss. 22, pp. 3823-3823
Open Access | Times Cited: 2
Targeting deubiquitinases for cancer therapy
Qian Xue, Daolin Tang, Xin Chen, et al.
Clinical and Translational Discovery (2023) Vol. 3, Iss. 5
Open Access | Times Cited: 4
SNRPB2 promotes triple‐negative breast cancer progression by controlling alternative splicing of MDM4 pre‐mRNA
Shiyi Yu, Yue Si, Jianzhong Yu, et al.
Cancer Science (2024)
Open Access | Times Cited: 1
USP7 facilitates deubiquitination of LRRC42 in colorectal cancer to accelerate tumorigenesis and augment Wnt/β-catenin signaling
Yunze Li, Sun Xin, Zhe Huang
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2024) Vol. 1872, Iss. 1, pp. 119859-119859
Closed Access | Times Cited: 1
Ubiquitin-specific protease 7 maintains c-Myc stability to support pancreatic cancer glycolysis and tumor growth
Jichun Gu, Xi Xiao, Caifeng Zou, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Discovery of a Highly Potent, Selective and Efficacious USP7 Degrader for the Treatment of Acute Lymphoblastic Leukemia
Miaomiao Xu, Jingfeng Fu, Yuan Pei, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 15, pp. 13197-13216
Closed Access | Times Cited: 1
A comprehensive molecular characterization of a claudin-low luminal B breast tumor
Sara Giovannini, Artem Smirnov, Livia Concetti, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
The deubiquitinase Usp7 in Drosophila melanogaster is required for synaptonemal complex maintenance
Cathleen M. Lake, Jennifer M. Gardner, Salam Briggs, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 36
Open Access | Times Cited: 1
USP31 promotes the inflammatory response of human lung organoids to lipopolysaccharide treatment
Wenbiao Xiao, Bingwen Lin, Ying Wang, et al.
Shock (2024) Vol. 63, Iss. 1, pp. 110-117
Closed Access
PROTAC as a novel anti-cancer strategy by targeting aging-related signaling
Yunhua Peng, Donghua Liu, Daoyuan Huang, et al.
Seminars in Cancer Biology (2024)
Closed Access
Page 1 - Next Page

Scroll to top